These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22464289)

  • 1. Can the battle against tuberculosis gain from epigenetic research?
    Esterhuyse MM; Linhart HG; Kaufmann SH
    Trends Microbiol; 2012 May; 20(5):220-6. PubMed ID: 22464289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New era in molecular epidemiology of tuberculosis in Japan].
    Takashima T; Iwamoto T
    Kekkaku; 2006 Nov; 81(11):693-707. PubMed ID: 17154049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes and regulatory networks involved in persistence of Mycobacterium tuberculosis.
    Wang X; Wang H; Xie J
    Sci China Life Sci; 2011 Apr; 54(4):300-10. PubMed ID: 21267668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential expression of human macrophage genes encoding cytokines and their regulatory elements after Mycobacterium tuberculosis infection].
    Xie J; Li Y; Yue J; Xu Y; Wang H; Liang L; Yu S; Hu C
    Wei Sheng Wu Xue Bao; 2003 Oct; 43(5):619-25. PubMed ID: 16281560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who puts the tubercle in tuberculosis?
    Russell DG
    Nat Rev Microbiol; 2007 Jan; 5(1):39-47. PubMed ID: 17160001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection.
    Stewart GR; Snewin VA; Walzl G; Hussell T; Tormay P; O'Gaora P; Goyal M; Betts J; Brown IN; Young DB
    Nat Med; 2001 Jun; 7(6):732-7. PubMed ID: 11385512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human macrophage host defense against Mycobacterium tuberculosis.
    Liu PT; Modlin RL
    Curr Opin Immunol; 2008 Aug; 20(4):371-6. PubMed ID: 18602003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type lectins in immune defense against pathogens: the murine DC-SIGN homologue SIGNR3 confers early protection against Mycobacterium tuberculosis infection.
    Tanne A; Neyrolles O
    Virulence; 2010; 1(4):285-90. PubMed ID: 21178456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis: Deadly combination.
    Kaufmann SH
    Nature; 2008 May; 453(7193):295-6. PubMed ID: 18480803
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of age on immunity to infection with Mycobacterium tuberculosis.
    Vesosky B; Turner J
    Immunol Rev; 2005 Jun; 205():229-43. PubMed ID: 15882357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis Transcription Machinery: Ready To Respond to Host Attacks.
    Flentie K; Garner AL; Stallings CL
    J Bacteriol; 2016 May; 198(9):1360-73. PubMed ID: 26883824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells.
    Puissegur MP; Botanch C; Duteyrat JL; Delsol G; Caratero C; Altare F
    Cell Microbiol; 2004 May; 6(5):423-33. PubMed ID: 15056213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].
    Colakoğlu S
    Mikrobiyol Bul; 2004; 38(1-2):155-67. PubMed ID: 15293916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing the interaction of pathogens with the host immune system.
    Jayachandran R; Scherr N; Pieters J
    Immunol Lett; 2009 Feb; 122(2):112-4. PubMed ID: 19135088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New genetic approaches shed light on TB virulence.
    Murry JP; Rubin EJ
    Trends Microbiol; 2005 Aug; 13(8):366-72. PubMed ID: 15982889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis: the genetics of vulnerability.
    Jabado N; Gros P
    Nature; 2005 Apr; 434(7034):709-11. PubMed ID: 15815612
    [No Abstract]   [Full Text] [Related]  

  • 20. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease.
    Cardona PJ
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):7-14. PubMed ID: 20049645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.